News

FRSCF

Generic Drugmaker Mylan Beats Earnings; Stock Jumps Over 6 Percent

Jacob Harper | Equities.com |

Mylan Inc. ($MYL) released its earnings report for the second quarter of 2013, and the drug manufacturer slightly beat analyst expectations. While the company fell slightly below revenue



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum